Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel [Yahoo! Finance]
Pluri Inc. (PLUR)
Company Research
Source: Yahoo! Finance
Pluri's MAIT platform enable s commercial scale production of powerful immune cells as a potential first-in-class, ready to use, “ off-the-shelf ” therapy for cancer patients Pluri's MAIT platform addresses the global immune cell engineering market, projected to reach approximately $11.7 billion by 2030, and the global cancer immunotherapy market, calculated at 136 billion in 2025 In addition to MAIT cells, Pluri's platform also supports the expansion of Tumor Infiltrating Lymphocytes (TILs), further broadening the scope of potential immune cell therapies in cancer immunotherapy and attracting attention in the growing TILs-focused research space HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company leveraging its proprietary platform for cell-based solutions to create a collaborative network of ventures, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued a patent c
Show less
Read more
Impact Snapshot
Event Time:
PLUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PLUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PLUR alerts
High impacting Pluri Inc. news events
Weekly update
A roundup of the hottest topics
PLUR
News
- Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing AchievedGlobeNewswire
- Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional InvestmentGlobeNewswire
- Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the YearGlobeNewswire
- Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare [Yahoo! Finance]Yahoo! Finance
- Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative SkincareGlobeNewswire
PLUR
Sec Filings
- 12/15/25 - Form SCHEDULE
- 12/9/25 - Form 8-K
- 12/8/25 - Form 4
- PLUR's page on the SEC website